BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Diabetic cardiomyopathy
1
Farrerol and the miR-29b-3p/sirtuin 1 pathway: A mechanistic breakthrough in protecting the diabetic heart
2/6/2026 8:43:33 AM | Browse: 56 | Download: 131
2
Microtubule affinity-regulating kinase 4 exacerbates diabetic cardiomyopathy by inhibiting UNC-51-like kinase 1-mediated mitochondrial autophagy
1/14/2026 8:09:14 AM | Browse: 35 | Download: 191
3
Right ventricular dysfunction in type 1 diabetic cardiomyopathy: An overlooked component?
1/14/2026 8:09:13 AM | Browse: 46 | Download: 142
4
Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway
12/15/2025 9:46:09 AM | Browse: 77 | Download: 346
5
Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related cardiomyopathy
12/15/2025 9:46:06 AM | Browse: 83 | Download: 211
6
Right ventricular dysfunctions in type 1 diabetic mice: A longitudinal study
10/15/2025 9:03:23 AM | Browse: 87 | Download: 393
7
Epicardial adipose tissue in diabetic myocardial disorder: Role of echocardiography
10/15/2025 9:03:21 AM | Browse: 105 | Download: 241
8
Farrerol ameliorates diabetic cardiomyopathy by inhibiting ferroptosis via miR-29b-3p/SIRT1 signaling pathway in endothelial cells
9/11/2025 9:41:58 AM | Browse: 296 | Download: 574
9
Ferroptosis: A novel therapeutic target for diabetic cardiomyopathy
6/13/2025 11:47:55 AM | Browse: 91 | Download: 466
10
Double-edged sword of L-arginine in diabetes: Exploring anti-inflammatory and antioxidant strategies
2/28/2025 10:47:24 AM | Browse: 223 | Download: 586
11
Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure
1/21/2025 6:56:34 AM | Browse: 108 | Download: 495
12
Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management
11/26/2024 9:16:41 AM | Browse: 97 | Download: 515
13
Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies
11/18/2024 3:30:39 AM | Browse: 122 | Download: 629
14
Identification of immune feature genes and intercellular profiles in diabetic cardiomyopathy
9/26/2024 8:51:02 AM | Browse: 128 | Download: 802
15
Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy
9/26/2024 8:51:01 AM | Browse: 156 | Download: 830
16
Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?
8/27/2024 3:11:19 PM | Browse: 158 | Download: 765
17
Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure
8/26/2024 12:59:17 PM | Browse: 63 | Download: 252
18
Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis
7/26/2024 6:56:09 AM | Browse: 132 | Download: 649
19
Diabetic cardiomyopathy: Emerging therapeutic options
7/26/2024 6:56:09 AM | Browse: 197 | Download: 592
20
Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy
6/11/2024 2:35:35 PM | Browse: 154 | Download: 710
21
Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome
4/12/2024 1:04:39 AM | Browse: 156 | Download: 1332
22
Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1a and inhibiting the RhoA/ROCK pathway
12/14/2023 9:36:12 AM | Browse: 291 | Download: 1452
23
Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization
12/14/2023 9:36:12 AM | Browse: 308 | Download: 1259
24
Potential therapeutic targets for the prevention of diabetic nephropathy: Glycyrrhetinic acid
12/14/2023 9:36:11 AM | Browse: 348 | Download: 985
25
Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology
11/14/2023 6:13:55 AM | Browse: 296 | Download: 1362
26
Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy
5/13/2022 10:36:57 AM | Browse: 725 | Download: 1729
27
Roles of transient receptor potential channel 6 in glucose-induced cardiomyocyte injury
4/14/2022 11:27:05 AM | Browse: 696 | Download: 2023
28
Role of novel biomarkers in diabetic cardiomyopathy
6/4/2021 1:47:10 PM | Browse: 801 | Download: 1881
29
Diabetic heart disease: A clinical update
4/9/2021 5:27:04 AM | Browse: 637 | Download: 1756
30
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
10/15/2019 3:36:45 AM | Browse: 952 | Download: 1561
31
Trace elements in diabetic cardiomyopathy: An electrophysiological overview
9/1/2014 3:13:00 PM | Browse: 1399 | Download: 1379
32
Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management
9/1/2014 3:02:00 PM | Browse: 1256 | Download: 1255
33
Cardiac autonomic neuropathy in patients with diabetes mellitus
9/1/2014 12:00:00 PM | Browse: 1707 | Download: 1657
34
Is diabetic cardiomyopathy a specific entity?
8/27/2014 5:24:00 PM | Browse: 1065 | Download: 1165
35
Mechanisms underlying the impaired contractility of diabetic cardiomyopathy
8/22/2014 2:47:00 PM | Browse: 1188 | Download: 1273